The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Lind Kevin Robert | Director | Grant(A) | 1K | $15.04 | $17K |
| Jun 30, 2026 | Jain Rita | Director | Grant(A) | 1K | $15.04 | $16K |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 3K | $12.65 | $36K |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 2K | $8.04 | $14K |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 5K | $20.00 | $93K |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 3K | — | $0 |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Jun 30, 2026 | Philip Ron M | Director | Grant(A) | 69 | $15.04 | $1K |
| Jun 23, 2026 | Philip Ron M | Director | Grant(A) | 40K | — | $0 |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 1K | $8.04 | $12K |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 1K | $18.00 | $26K |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 1K | — | $0 |
| Jun 10, 2026 | Doyle Mittie | Chief Medical Officer | Tax withholding(F) | 1K | $13.10 | $14K |
| Jun 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Tax withholding(F) | 138 | $13.10 | $2K |
| Jun 10, 2026 | Riley Jennifer | Chief Strategy Officer | Tax withholding(F) | 588 | $13.10 | $8K |
| Jun 10, 2026 | Varki Paul | Chief Legal Officer | Tax withholding(F) | 1K | $13.10 | $14K |
| Jun 2, 2026 | Truex Samantha | Director | Grant(A) | 20K | — | $0 |
| Jun 2, 2026 | Kantoff Aaron | Director | Grant(A) | 20K | — | $0 |
| Jun 2, 2026 | Jain Rita | Director | Grant(A) | 20K | — | $0 |
| Jun 2, 2026 | Lind Kevin Robert | Director | Grant(A) | 20K | — | $0 |
| Jun 2, 2026 | Heffernan Michael Thomas | Director | Grant(A) | 30K | — | $0 |
| Jun 2, 2026 | Kaplan Gilla | Director | Grant(A) | 20K | — | $0 |
| May 28, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | — | $0 |
| May 28, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 679 | $16.00 | $11K |
| May 28, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | $8.04 | $5K |
| May 21, 2026 | Riley Jennifer | Chief Strategy Officer | Grant(A) | 34K | — | $0 |
| May 21, 2026 | Doyle Mittie | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| May 21, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Grant(A) | 40K | — | $0 |
| May 21, 2026 | Varki Paul | Chief Legal Officer | Grant(A) | 24K | — | $0 |
| May 21, 2026 | Neil Garry Arthur | Chief Executive Officer, Director | Grant(A) | 100K | — | $0 |
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 3K | — | $0 |
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 3K | $18.76 | $56K |
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 3K | $12.65 | $38K |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 19K | — | $0 |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 19K | $24.12 | $449K |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 19K | $9.88 | $184K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 29K | — | $0 |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 78K | — | $0 |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 10K | $22.88 | $230K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 19K | $22.41 | $426K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 45K | $21.20 | $953K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 5K | $19.65 | $98K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 28K | $18.03 | $496K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 29K | $8.04 | $230K |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 78K | $12.65 | $985K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 47K | — | $0 |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 9K | $22.57 | $201K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 9K | $21.37 | $197K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 3K | $20.76 | $56K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 12K | $19.28 | $238K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 14K | $18.55 | $257K |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 47K | $8.04 | $378K |
| May 6, 2026 | Chan Mitchell | Director | Sell(S) | 3K | $22.88 | $72K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Option exercise(M) | 13K | — | $0 |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Option exercise(M) | 63K | — | $0 |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Sell(S) | 400 | $23.71 | $9K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Sell(S) | 9K | $22.70 | $210K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Sell(S) | 23K | $21.22 | $485K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Sell(S) | 5K | $19.78 | $103K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Sell(S) | 37K | $18.91 | $707K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Option exercise(M) | 13K | $8.04 | $101K |
| May 6, 2026 | Varki Paul | Chief Legal Officer | Option exercise(M) | 63K | $13.43 | $839K |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | — | $0 |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 1K | — | $0 |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 2K | $16.00 | $27K |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | $8.04 | $5K |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 1K | $12.65 | $13K |
| Apr 30, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 8K | $13.23 | $112K |
| Apr 29, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 8K | $13.09 | $111K |
| Apr 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Apr 6, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 4K | $18.01 | $72K |
| Apr 6, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 4K | $12.65 | $50K |
| Apr 2, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 2K | $17.57 | $31K |
| Apr 2, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 6K | $17.02 | $106K |
| Apr 1, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 7K | $16.83 | $126K |
| Apr 1, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell(S) | 500 | $15.86 | $8K |
| Apr 1, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | — | $0 |
| Apr 1, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 679 | $16.00 | $11K |
| Apr 1, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 679 | $8.04 | $5K |
| Mar 31, 2026 | Jain Rita | Director | Grant(A) | 1K | $12.13 | $16K |
| Mar 31, 2026 | Lind Kevin Robert | Director | Grant(A) | 1K | $12.13 | $17K |
| Mar 28, 2026 | Kaplan Gilla | Director | Option exercise(M) | 3K | — | — |
| Mar 28, 2026 | Kaplan Gilla | Director | Option exercise(M) | 3K | — | $0 |
| Mar 28, 2026 | Neil Garry Arthur | Chief Executive Officer, Director | Option exercise(M) | 65K | — | — |
| Mar 28, 2026 | Neil Garry Arthur | Chief Executive Officer, Director | Tax withholding(F) | 22K | $13.89 | $304K |
| Mar 28, 2026 | Neil Garry Arthur | Chief Executive Officer, Director | Option exercise(M) | 65K | — | $0 |
| Mar 28, 2026 | Chan Mitchell | Director | Option exercise(M) | 3K | — | — |
| Mar 28, 2026 | Chan Mitchell | Director | Option exercise(M) | 3K | — | $0 |
| Mar 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Tax withholding(F) | 8K | $13.89 | $114K |
| Mar 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 24K | — | — |
| Mar 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Option exercise(M) | 24K | — | $0 |
| Mar 28, 2026 | Kantoff Aaron | Director | Option exercise(M) | 3K | — | — |
| Mar 28, 2026 | Kantoff Aaron | Director | Option exercise(M) | 3K | — | $0 |
| Mar 28, 2026 | Goldman Jonathan | Director | Option exercise(M) | 3K | — | — |
| Mar 28, 2026 | Goldman Jonathan | Director | Option exercise(M) | 3K | — | $0 |
| Mar 28, 2026 | Truex Samantha | Director | Option exercise(M) | 3K | — | — |
| Mar 28, 2026 | Truex Samantha | Director | Option exercise(M) | 3K | — | $0 |
| Mar 16, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 20K | $12.65 | $247K |
| Mar 16, 2026 | Doyle Mittie | Chief Medical Officer | Option exercise(M) | 6K | $8.04 | $48K |
| Mar 16, 2026 | Doyle Mittie | Chief Medical Officer | Sell(S) | 25K | $16.15 | $412K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).